EarCentric EX2 vs RCA In-Ear

The EarCentric EX2 is a behind-the-ear prescription hearing aid priced at $218, positioning it as a budget-friendly option in the prescription category. In HearAdvisor's lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking #35 of 39 prescription hearing aids tested. This 2021 release demonstrates mixed performance across key metrics. Its standout strength is feedback handling, scoring an excellent 4.7/5—essentially matching the category average and indicating reliable stability during movement. However, speech performance is a significant weakness: speech in quiet scores just 1.0/5 (2.40 points below the category average of 3.40), and speech in noise scores 1.0/5 (1.11 points below average). These low absolute scores suggest limited audibility enhancement in our standardized test conditions. Own-voice comfort scores 2.3/5, which is mixed in absolute terms and 0.40 points below the category average. Music streaming scored 0.0/5, indicating this device is not suited for audio entertainment purposes. The EarCentric EX2 may appeal to budget-conscious consumers who prioritize cost over performance, but alternatives exist at similar or lower price points with stronger test results. The RxEars Rxi, available in the same price range, scored 4.07/5 in our testing. Consumers seeking entry-level amplification should weigh the significant speech clarity limitations against the low purchase price.

The RCA In-Ear is a budget-priced OTC hearing aid available for $249, earning a C grade with a SoundScore of 2.8/5 in our lab testing. This places it near the bottom of the OTC hearing aid category, ranking 64th out of 65 devices tested. In our standardized testing, the RCA In-Ear shows a mixed performance profile. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users are unlikely to experience whistling or squealing during normal wear. Own-voice comfort scores 2.6/5, which is essentially at the category average (+0.09 points), offering mixed but acceptable performance for how your own voice sounds while wearing the devices. However, the core speech performance metrics present significant limitations. Speech in quiet scores just 1.0/5, falling 1.79 points below the category average, and speech in noise also scores 1.0/5, sitting 0.48 points below average. Music streaming scored 0.0/5, indicating this device is not suitable for audio entertainment purposes. At this price point, buyers have considerably stronger options. Competitors like the Lucid Enrich Pro and JLab Hear OTC offer better sound performance at lower prices. The RCA In-Ear may appeal to those prioritizing feedback-free wear above speech clarity, but most users seeking meaningful hearing benefit should consider higher-performing alternatives in this budget segment.